Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 120,500 | 179,300 | 189,500 | 590,600 | 419,700 |
| Receivables | 324,600 | 302,700 | 304,800 | 240,400 | 509,300 |
| Inventories | 281,500 | 269,800 | 284,700 | 230,800 | 427,600 |
| Income taxes - deferred | 37,400 | 38,400 | 31,600 | 23,600 | 40,000 |
| Other current assets | 500,200 | 428,600 | 480,700 | 521,200 | 28,100 |
| TOTAL | $1,264,200 | $1,218,800 | $1,291,300 | $1,606,600 | $1,424,700 |
| Non-Current Assets | |||||
| PPE Net | 872,100 | 835,300 | 805,600 | 699,400 | 1,124,700 |
| Investments And Advances | 1,400 | 1,700 | 2,400 | 0 | 19,900 |
| Intangibles | 691,400 | 709,000 | 723,500 | 351,000 | 1,011,700 |
| Other Non-Current Assets | 1,132,100 | 1,159,400 | 1,133,100 | 1,201,400 | 134,900 |
| TOTAL | $2,697,000 | $2,705,400 | $2,664,600 | $2,251,800 | $2,291,200 |
| Total Assets | $3,961,200 | $3,924,200 | $3,955,900 | $3,858,400 | $3,715,900 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,500 | 139,100 | 143,600 | 10,800 | 8,000 |
| Accounts payable and accrued liabilities | 216,900 | 176,400 | 166,000 | 141,300 | 359,000 |
| Accrued Expenses | 145,600 | 177,400 | 185,200 | 134,200 | 201,700 |
| Other current liabilities | 245,800 | 265,900 | 288,800 | 285,400 | N/A |
| TOTAL | $644,600 | $810,800 | $832,600 | $588,600 | $599,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 851,800 | 567,400 | 529,900 | 807,200 | 637,900 |
| Other Non-Current Liabilities | 664,300 | 671,400 | 613,300 | 618,700 | 611,300 |
| TOTAL | $1,582,700 | $1,310,400 | $1,245,700 | $1,482,700 | $1,324,800 |
| Total Liabilities | $2,227,300 | $2,121,200 | $2,078,300 | $2,071,300 | $1,923,800 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 83,891 | 89,651 | 91,182 | 92,115 | 91,972 |
| Common Shares | 500 | 500 | 500 | 500 | 500 |
| Retained earnings | 1,669,200 | 1,419,200 | 1,601,200 | 1,553,600 | 1,523,700 |
| Other shareholders' equity | -82,300 | 160,700 | -32,600 | -68,700 | -27,700 |
| TOTAL | $1,733,900 | $1,803,000 | $1,877,600 | $1,787,100 | $1,792,100 |
| Total Liabilities And Equity | $3,961,200 | $3,924,200 | $3,955,900 | $3,858,400 | $3,715,900 |